Sonidegib D4 | CAS 2714431-00-0 - Request Quote
Sonidegib D4
| SZ CAT No: | SZ-S070D01 |
| CAS No | 2714431-00-0 |
| Mol.F. | C26H22D4F3N3O3 |
| Mol.Wt. | 489.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sonidegib D4 is chemically N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-2',3',5',6'-d4-3-carboxamide. It is also known as Erismodegib D4. Sonidegib D4 is supplied with detailed characterization data compliant with regulatory guideline. Sonidegib D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sonidegib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2714431-00-0
Purchase 2714431-00-0
Order 2714431-00-0
Enquire 2714431-00-0
price of 2714431-00-0
2714431-00-0 Supplier
2714431-00-0 Manufacturer
2714431-00-0 Exporter
buy high quality Sonidegib D4
Purchase Sonidegib D4
Sonidegib D4 suppliers
Sonidegib D4 manufacturers
Sonidegib D4 price
Order Sonidegib D4
Enquire Sonidegib D4
Sonidegib D4 cost
Sonidegib D4 Supplier
Sonidegib D4 Distributor
Sonidegib D4 for Method Validation
Sonidegib Reference Standard
Sonidegib D4 for ANDA Filing
Sonidegib D4 for Forced Degradation Studies
Sonidegib D4 Identification Standards
Sonidegib D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


